 Optimal conditioning regimens for older patients with myelofibrosis undergoing allogeneic hematopoietic cell transplant are not known . Likewise the role of dose intensity is not clear .

@highlight Myeloablative pharmacokinetic guided i.v. busulfan is safe in older myelofibrosis patients.
@highlight It reduced relapse without increasing NRM even in older patients.
@highlight Intermediate 2 DIPSS plus risk has better outcomes than high risk disease.
